Business / Finance

RSS

Astex fourth quarter total revenues increase to $21.2 million

Astex Pharmaceuticals, Inc., today reported financial results for the fourth quarter and year ended December 31, 2011.

5 Mar 2012

AMAG fourth quarter total revenues decrease to $14.9 million

AMAG Pharmaceuticals, Inc. a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2011. As of December 31, 2011, the company's cash, cash equivalents and investments totaled approximately $230 million.

5 Mar 2012

Univita Health announces acquisition of All-Med Services of Florida

Univita Health, a leader in providing home-based care management, has announced the acquisition of All-Med Services of Florida (All-Med).

5 Mar 2012

HASCO Medical acquires Ride-Away Handicap Equipment

HASCO Medical, Inc., www.HascoMed.com a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, is pleased to announce that the Company has completed the acquisition of all of the outstanding capital stock of Ride-Away Handicap Equipment Corp., a closely-held New Hampshire corporation (Ride-Away).

5 Mar 2012

Omega announces private placement of $400M senior notes offering

Omega Healthcare Investors, Inc. announced today its intention to offer $400 million aggregate principal amount of its senior notes due 2024 in a private placement, subject to market and other conditions.

5 Mar 2012

Varian to acquire InfiMed

Varian Medical Systems, Inc., today announced it has reached an agreement to acquire InfiMed, Inc., a privately-owned, leading supplier of workstations including hardware and software for processing diagnostic X-ray images. The acquisition, which is expected to close in early April subject to the satisfaction of certain closing conditions, will operate within Varian's X-Ray Products segment.

5 Mar 2012

Simulations Plus second quarter revenues increase to record $2.789M

Simulations Plus, Inc., a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported preliminary revenues for its second quarter of fiscal year 2012 ended February 29, 2012 (2QFY12).

5 Mar 2012

Access full year 2011 revenues increase 284%

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology and cancer supportive care,announced preliminary revenue results for fourth quarter 2011 and full year 2011. Fourth quarter MuGard product sales increased 400% over third quarter product sales.

5 Mar 2012

Acadia acquires three inpatient psychiatric hospitals from Haven Behavioral Healthcare

Acadia Healthcare Company, Inc. today announced that it has completed the previously announced acquisition of three inpatient psychiatric hospitals from Haven Behavioral Healthcare for $91 million in cash.

5 Mar 2012

Immediate Clinic acquires Doctors Express

The Ensign Group, Inc., the parent company of the Ensign group of skilled nursing, rehabilitative care services, hospice care, assisted living and urgent care companies, today announced that its urgent care joint venture, Immediate Clinic LLC, has acquired Doctors Express, a national urgent care franchise system.

5 Mar 2012

USPI fourth quarter consolidated net revenues increase 5% to $162.0M

United Surgical Partners International, Inc. today announced results for the fourth quarter and year ended December 31, 2011.

1 Mar 2012

Ipsen total revenues increase 5.5% to €1,234.9M for the full year 2011

The Board of Directors of Ipsen, chaired by Marc de Garidel, met on 28 February 2012 to review the Group's results for 2011, published today.

29 Feb 2012

EpiCept fourth quarter revenue decreases to $0.2 million

EpiCept Corporation today announced operating and financial results for the fourth quarter and full year ended December 31, 2011, and provided an update on the Company's key business initiatives.

29 Feb 2012

GI Dynamics reports revenues of US$234,000 for year ended 31 December 2011

GI Dynamics, Inc., a company pioneering the development of effective, non-surgical approaches for treating type 2 diabetes and obesity, is pleased to provide its financial results for the year ended 31 December 2011.

28 Feb 2012

ICON announces acquisition of PriceSpective

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of PriceSpective LLC, a global leader in value strategy consulting.

28 Feb 2012

Dompé enters definitive agreement to acquire Anabasis

Dompé, one of Italy's leading biopharmaceutical companies, announced today that it has entered into a definitive agreement to acquire 100% of Anabasis Srl, a privately held Italian research and development biopharmaceutical company, focused on ocular diseases.

28 Feb 2012

Shanghai ShowStar, UBM Asia form JV company

UBM Asia announces that it has formed a JV company, Shanghai UBM ShowStar Exhibition Co Ltd with Shanghai ShowStar Exhibition Service Co Ltd, owner of China International Exhibition & Symposium on Dental Equipment, Technology & Products.

28 Feb 2012

Simpler Consulting forms new entity in India

Simpler Consulting, L.P., a leading global management consulting firm, today announced the formation of a new entity, Simpler Consulting India to expand the Company's geographic footprint to bring Lean management services to healthcare and manufacturing organizations in India.

28 Feb 2012

Biogen Idec, Samsung Biologics establish joint venture to develop and market biosimilars

Samsung Biologics and Biogen Idec announced today that the companies have established their joint venture, Samsung Bioepis Co., Ltd., to develop, manufacture and market biosimilars in keeping with their agreement announced in December.

28 Feb 2012

St. Jude Medical quarterly dvidend increases to $0.92 per share

St. Jude Medical, Inc., a global medical device company, today announced that its Board of Directors declared a 10 percent increase in the company's quarterly dividend to $0.23 per common share. At the new rate, the annual dividend would be $0.92 per share, compared to the previous annual dividend of $0.84 per share.

27 Feb 2012